The narrative is always the same. Fuel prices go up, transport costs climb, and suddenly the headlines scream that life-saving medicine is a "luxury" for the poor. It’s a tear-jerker. It’s easy to write. It’s also fundamentally wrong.
The tragedy in Pakistan isn't that medicine is becoming too expensive. The tragedy is that we have spent decades pretending that price controls actually work. By forcing pharmaceutical prices to stay artificially low while global supply chains and energy costs fluctuate, the government hasn't saved the poor—it has created a black market, triggered massive shortages, and driven legitimate manufacturers out of the country.
If you want to save lives, you stop obsessing over the price tag and start looking at availability. A cheap pill that doesn't exist on the shelf saves zero lives.
The Price Control Paradox
The general public and most "social justice" journalists suffer from the same delusion: they believe a government mandate can override the laws of physics and economics. When fuel prices spike, the cost of everything moves. Raw materials (APIs) imported from China or India don't get a discount because our currency is devaluing. Electricity for cold-chain storage doesn't get cheaper because a regulator says so.
When you freeze the price of a drug but let the cost of making it double, you aren't "protecting the consumer." You are ordering the manufacturer to commit financial suicide. Business owners are not charities. When the math doesn't work, they stop production.
I have seen local plants shut down lines for basic pediatric antibiotics simply because the plastic for the bottle cost more than the government-mandated retail price of the finished product. This isn't a "fuel shock." It’s a policy failure. The "luxury" isn't the price; the luxury is actually finding the medicine in a pharmacy instead of a shady back-alley dealer at a 500% markup.
The Black Market Tax
Let’s look at the "People Also Ask" logic that permeates this debate. People ask: "How can the government make medicine affordable?"
That is the wrong question. The real question is: "Why does the government prefer a thriving black market over a stable legal one?"
When a life-saving drug—take heparin or certain insulin brands—disappears from legal shelves due to price caps, it doesn't vanish from the earth. It migrates. It moves to the unregulated grey market. There, the "fuel price shock" is passed on to the consumer ten times over, with no guarantee of quality, storage temperature, or authenticity.
By refusing to allow a 15% or 20% price adjustment in line with inflation and energy costs, the state forces the poorest citizens to pay a 200% premium to smugglers. This is the "lazy consensus" of populist politics: looking like a hero on paper while killing people in practice.
Why Quality Fleeing is the Real Crisis
In the last decade, we’ve seen a mass exodus of multinational pharmaceutical companies from Pakistan. Why? Because the regulatory environment is a nightmare of arbitrary caps and delayed approvals.
When a multinational leaves, they don't just take their branding. They take their quality standards, their research, and their specialized life-saving molecules. They are replaced by "under-the-radar" local outfits that might—or might not—be following Good Manufacturing Practices (GMP).
We are trading safety for the illusion of affordability. I’d rather pay 500 rupees for a drug that I know contains the active ingredient than 50 rupees for a chalk pill made in a basement. The current "fuel price" outcry is a distraction from the fact that our regulatory system has de-incentivized quality for thirty years.
The Math of the Supply Chain
Let’s get technical for a moment. Most people think "fuel prices" just means the truck that delivers the box to the pharmacy. That is a fraction of the problem.
Pharmaceutical manufacturing is energy-intensive.
- HVAC Systems: Cleanrooms must run 24/7 at precise temperatures and humidity levels. If the power grid fails or diesel for generators becomes unaffordable, the batch is ruined.
- Sterilization: Autoclaves and industrial-scale heating require massive energy inputs.
- Import Logistics: 90% of Pakistan’s raw materials are imported. If the PKR devalues—which is tied directly to our energy imports—the cost of the "dirt" used to make the pill skyrockets instantly.
When the Drug Regulatory Authority of Pakistan (DRAP) waits six months to even discuss a price adjustment, the manufacturer has already bled out.
The "Hard Truth" Prescription
If we want to fix this, we have to stop the emotional blackmail. Here is the unconventional reality:
- Deregulate Prices for Non-Essential Drugs: Let the market decide the price of a cough syrup or a vitamin. Competition will drive those prices down naturally. Use that saved regulatory energy to focus on the top 100 life-saving medicines.
- Automatic Inflation Indexing: The price of medicine should be linked to a basket of costs (fuel, currency, CPI). No more waiting for a committee to meet while people die. If fuel goes up 30%, the drug price moves by the calculated margin automatically.
- Targeted Subsidies, Not Price Caps: If the government wants to help the poor, they should give them cash or health cards to buy the medicine. Do not force the manufacturer to subsidize the entire population. That is a fast track to a national shortage.
The downside? Yes, the price at the counter will go up. People will complain. But the shelves will be full. The black market will starve. And the "life-saving" part of the medicine will actually be available to save a life.
Stop asking why the medicine is expensive. Start asking why the government thinks a price tag is more important than a pulse.
Burn the price control manuals. Open the market. Let the pharmacies stock their shelves. Anything else is just a slow-motion execution of the very people you claim to protect.
